Beacon Biosignals
3 employees
Artificial Intelligence (AI)
Series B · $132.0M
Open positions (21)
Company details
Team Size3
IndustryArtificial Intelligence (AI)
Funding
Total raised
$132.0M
Last stage
Series B
Investors
Innoviva
Total raised
$132.0M
Last stage
Series B
Investors
Jarrett Revels
Co-founded Beacon Biosignals in 2019. Serves on the board of 1 company.
Sydney Cash
Co-founded Beacon Biosignals in 2019.
Jacob Donoghue
MD from Harvard Medical School and PhD in Neuroscience from MIT. Previously a researcher at Massachusetts General Hospital. Leads Beacon's efforts in AI-powered EEG analytics for brain health.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.